Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
 
 
DownloadE-Mail
 Lokale TagsFreigabegeschichteDetailsÜbersicht
  Benzimidazole-2-one: A novel anchoring principle for antagonizing p53-Mdm2

Wang, W., Cao, H., Wolf, S., Camacho-Horvitz, M. S., Holak, T., & Domling, A. (2013). Benzimidazole-2-one: A novel anchoring principle for antagonizing p53-Mdm2. BIOORGANIC & MEDICINAL CHEMISTRY, 21(14), 3982-3995. doi:10.1016/j.bmc.2012.06.020.

Item is

 

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:
Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-0014-4594-8 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-0014-4595-6
Genre: Zeitschriftenartikel

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Wang, Wei1, Autor
Cao, Haiping1, Autor
Wolf, Siglinde2, Autor           
Camacho-Horvitz, Miguel S.1, Autor
Holak, Tad2, Autor           
Domling, Alexander1, Autor
Affiliations:
1external, ou_persistent22              
2Holak, Tad / NMR Spectroscopy, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565154              

Inhalt

einblenden:
ausblenden:
Schlagwörter: SUPPRESSOR TRANSACTIVATION DOMAIN; PROTEIN-PROTEIN INTERACTIONS; 3-COMPONENT REACTION; DRUG DISCOVERY; NMR; P53; INHIBITORS; MDM2; POTENT; DERIVATIVESProtein-protein interaction; ANCHOR; Tryptophan; Multicomponent reaction; Ugi; p53 mdm2; Selectivity;
 Zusammenfassung: Herein we propose the benzimidazole-2-one substructure as a suitable tryptophan mimic and thus a reasonable starting point for the design of p53 Mdm2 antagonists. We devise a short multicomponent reaction route to hitherto unknown 2-(2-oxo-2,3-dihydro-1H-benzoidlimidazol-1-yl)acetamides by reacting mono N-carbamate protected phenylenediamine in a Ugi-3 CR followed by base induced cyclisation. Our preliminary synthesis and screening results are presented here. The finding of the benzimidazolone moiety as a tryptophan replacement in mdm2 is significant as it offers access to novel scaffolds with potentially higher selectivitY and potency and improved biological activities. Observing low mu M affinities to mdm2 by NMR and fluorescence polarization we conclude that the 2-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)acetamide scaffold might be a good starting point to further optimize the affinities to Mdm2. (C) 2012 Elsevier Ltd. All rights reserved.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2013
 Publikationsstatus: Erschienen
 Seiten: 14
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: Expertenbegutachtung
 Identifikatoren: ISI: 000320838200002
DOI: 10.1016/j.bmc.2012.06.020
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: BIOORGANIC & MEDICINAL CHEMISTRY
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND : PERGAMON-ELSEVIER SCIENCE LTD
Seiten: - Band / Heft: 21 (14) Artikelnummer: - Start- / Endseite: 3982 - 3995 Identifikator: ISSN: 0968-0896